Sleath Betsy, Slota Catherine, Blalock Susan J, Sayner Robyn, Carpenter Delesha M, Muir Kelly W, Hartnett Mary Elizabeth, Robin Alan L
*PhD †PhD candidate ‡PharmD §PhD, MSPH ∥MD University of North Carolina Eshelman School of Pharmacy (BS, CS, SJB, RS, DMC), Cecil G. Sheps Center for Health Services Research (BS), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Ophthalmology, School of Medicine, Duke University, Durham, North Carolina (KWM); Durham VA Medical Center, Health Services Research and Development, Durham, North Carolina (KWM); Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah (MEH); and Department of International Health, Bloomberg School of Public Health, and Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, Maryland (ALR).
Optom Vis Sci. 2014 May;91(5):549-55. doi: 10.1097/OPX.0000000000000244.
The purpose of this preliminary study was to describe the extent to which providers used collaborative goal setting and individualized assessment with patients who were newly prescribed glaucoma medications.
English-speaking glaucoma suspect patients from six ophthalmology clinics who were newly prescribed glaucoma medications had their medical visits videotaped and were interviewed after the visits. The videotapes were transcribed and coded to examine provider use of collaborative goal setting and individualized assessment.
Fifty-one patients seeing 12 ophthalmologists participated. Providers gave patients glaucoma treatment options during 37% of the visits; only five providers gave patients treatment options Providers asked for patient treatment preferences in less than 20% of the visits; only two providers asked for patient treatment preferences. Providers were significantly more likely to ask African American patients for their preferences or ideas concerning treatment than non-African American patients (Pearson χ² = 4.1, p = 0.04). Providers were also significantly more likely to ask African American patients about their confidence in using glaucoma medication regularly than non-African American patients (Pearson χ² = 8.2, p = 0.004). Providers asked about patient views about glaucoma in less than 20% of the visits; five providers asked patients their views on glaucoma and its treatment. Providers were significantly more likely to ask African American patients about their views on glaucoma than non-African American patients (Pearson χ² = 5.62, p = 0.02).
Eye care providers often did not use collaborative goal setting or conduct individualized assessments of patient views on glaucoma when prescribing treatment for the first time.
本初步研究的目的是描述医疗服务提供者在为新开具青光眼药物的患者设定协作目标和进行个性化评估方面的程度。
来自六家眼科诊所的新开具青光眼药物的讲英语的青光眼疑似患者的就诊过程被录像,并在就诊后接受访谈。录像带被转录并编码,以检查医疗服务提供者对协作目标设定和个性化评估的使用情况。
51名患者接受了12名眼科医生的诊治。在37%的就诊过程中,医疗服务提供者向患者提供了青光眼治疗方案;只有5名医疗服务提供者向患者提供了治疗方案。在不到20%的就诊过程中,医疗服务提供者询问了患者的治疗偏好;只有2名医疗服务提供者询问了患者的治疗偏好。与非非裔美国患者相比,医疗服务提供者向非裔美国患者询问其对治疗的偏好或想法的可能性显著更高(Pearson χ² = 4.1,p = 0.04)。与非非裔美国患者相比,医疗服务提供者向非裔美国患者询问其定期使用青光眼药物的信心的可能性也显著更高(Pearson χ² = 8.2,p = 0.004)。在不到20%的就诊过程中,医疗服务提供者询问了患者对青光眼的看法;5名医疗服务提供者询问了患者对青光眼及其治疗的看法。与非非裔美国患者相比,医疗服务提供者向非裔美国患者询问其对青光眼看法的可能性显著更高(Pearson χ² = 5.62,p = 0.02)。
眼科护理提供者在首次开出处方治疗青光眼时,往往没有采用协作目标设定或对患者对青光眼的看法进行个性化评估。